Topic

Garadacimab (anti-FXIIa) — FDA-approved 2025

A collection of 12 issues

How to Get Garadacimab (Andembry) Covered by UnitedHealthcare in Illinois: Timeline, Appeals & Documentation

Quick Answer: Getting Garadacimab Covered by UnitedHealthcare in Illinois Garadacimab (Andembry) requires prior authorization from UnitedHealthcare through OptumRx. The fastest approval path involves submitting complete clinical documentation showing confirmed HAE diagnosis, failed prior therapies, and REMS compliance within 1-5 business days. If denied, Illinois residents have strong appeal rights with

Garadacimab (Andembry) Coverage by Humana in Texas: Formulary Alternatives, Appeals, and Prior Authorization Guide

Quick Answer: Getting Garadacimab (Andembry) Covered by Humana in Texas Garadacimab is not on Humana's 2025 Medicare formulary, requiring a formulary exception request. Texas residents have strong appeal rights through internal reviews (65 days to file) and external reviews via Independent Review Organizations. First step: Have your prescriber